Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia.
Exp Hematol Oncol. 2023 Sep 22;12(1):81. doi: 10.1186/s40164-023-00445-8.
Exp Hematol Oncol. 2023.
PMID: 37740239
Free PMC article.
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia.
Schneider P, Wander P, Arentsen-Peters STCJM, Vrenken KS, Rockx-Brouwer D, Adriaanse FRS, Hoeve V, Paassen I, Drost J, Pieters R, Stam RW.
Schneider P, et al. Among authors: adriaanse frs.
Int J Mol Sci. 2023 Aug 25;24(17):13207. doi: 10.3390/ijms241713207.
Int J Mol Sci. 2023.
PMID: 37686014
Free PMC article.
Item in Clipboard
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1.
Closa A, Reixachs-Solé M, Fuentes-Fayos AC, Hayer KE, Melero JL, Adriaanse FRS, Bos RS, Torres-Diz M, Hunger SP, Roberts KG, Mullighan CG, Stam RW, Thomas-Tikhonenko A, Castaño JP, Luque RM, Eyras E.
Closa A, et al. Among authors: adriaanse frs.
NAR Cancer. 2022 Dec 9;4(4):zcac041. doi: 10.1093/narcan/zcac041. eCollection 2022 Dec.
NAR Cancer. 2022.
PMID: 36518527
Free PMC article.
Item in Clipboard
A CRISPR/Cas9 engineered MplS504N mouse model recapitulates human myelofibrosis.
Adriaanse FRS, Kamens JL, Vogel P, Sakurada SM, Pruett-Miller SM, Stam RW, Michel Zwaan C, Gruber TA.
Adriaanse FRS, et al.
Leukemia. 2022 Oct;36(10):2535-2538. doi: 10.1038/s41375-022-01684-0. Epub 2022 Aug 23.
Leukemia. 2022.
PMID: 35999261
No abstract available.
Item in Clipboard
Cite
Cite